Analyzes of the role of urokinase receptor cell growth
尿激酶受体细胞生长作用的分析
基本信息
- 批准号:06670052
- 负责人:
- 金额:$ 1.28万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for General Scientific Research (C)
- 财政年份:1994
- 资助国家:日本
- 起止时间:1994 至 1995
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
(1) We studied the expression of uPAR mPNA in cultured cell line (U-937). The expression of uPAR mRNA was enhanced by phorbol-ester stimulation, which resulted in the higher accumulation of uPAR antigen both in the medium and in the cell lysate. We detected two different forms of uPAR mRNA,one of which coodes mature uPAR and another codes soluble uPAR.Employing two different DNA probes, each of which detects only one of these two different mRNAs, we demonstrated that both forms increased after phorbol ester stimulation.(2) We assayd antigen levels of soluble uPAR in cancer patients plasma. In lung cancer patients, plasma soluble uPAR levels were significantly higher than those in normal controls. Either by proteolytic cleavage of mature uPAR or by increasing alternatively spliced mRNA for soluble uPAR,plasma uPAR seems to be elevated. Plasma soluble uPAR level might be a useful tumor marker of lung cancer.(3) The expression of uPA mRNA in lung cancer tissue was significantly higher than that in normal lung tissue. The expression of uPAR mRNA,however, did not differ between cancer tissue and normal lung tissue. mRNA of both PAI-1 and PAI-2 were also higher in lung cancer tissue than those in normal counter parts, which are in accordance with our previous results of their antigen level.(4) We analyzed the effects of either uPA alone or of uPA together with its specific inhibitor on cell growth using U937. uPA alone slightly enhanced cell growth. Simultancous use of its inhibitor, however, did not influence cell growth. Since U937 without treatment by phorbol-ester may not have enough amounts of uPAR on cell surface, further experiment using other cell line must be needed to clarify the effect of uPA and its inhibitors on cell growth.
(1)我们研究了uPAR mPNA在培养细胞系U-937中的表达。佛波醇酯刺激可增强uPAR mRNA的表达,从而导致uPAR抗原在培养基和细胞裂解液中的积累。我们检测到两种不同形式的uPAR mRNA,其中一种编码成熟uPAR,另一种编码可溶性uPAR。使用两种不同的DNA探针,每种探针只能检测这两种不同mRNA中的一种,我们证明了两种形式在佛波醇酯刺激后都增加。(2)我们测定了癌症患者血浆中可溶性uPAR的抗原水平。肺癌患者血浆可溶性uPAR水平显著高于正常对照组。通过成熟uPAR的蛋白水解裂解或通过增加可溶性uPAR的选择性剪接mRNA,血浆uPAR似乎升高。血浆可溶性uPAR水平可能是肺癌的一个有用的肿瘤标志物。(3)肺癌组织中uPA mRNA的表达明显高于正常肺组织。而uPAR mRNA的表达在癌组织和正常肺组织中无明显差异。派-1和派-2的mRNA在肺癌组织中的表达也高于正常对照组织,这与我们以前的研究结果相一致。(4)我们使用U937分析了单独的uPA或uPA与其特异性抑制剂一起对细胞生长的影响。单独的uPA略微增强细胞生长。然而,同时使用其抑制剂并不影响细胞生长。由于未经佛波酯处理的U937细胞表面可能没有足够量的uPAR,因此必须使用其他细胞系进行进一步的实验以阐明uPA及其抑制剂对细胞生长的影响。
项目成果
期刊论文数量(108)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
浦野哲盟: "t-PAの分子構造と血栓溶解機構" 病態生理. 13(9). 673-679 (1994)
Tetsumei Urano:“t-PA 的分子结构和溶栓机制”病理生理学 13(9) (1994)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
浦野哲盟 等: "ストレス負荷による血小板機能及び線溶活性の変化と、血中セロトニン関連物質との関係" 生理学研究所年報. 16. 334- (1995)
Tetsumei Urano 等:“压力负荷引起的血小板功能和纤维蛋白溶解活性的变化及其与血液血清素相关物质的关系”国家生理科学研究所年度报告 16. 334- (1995)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Malyszko, J., et al: "Relationships between serum lipids, serotonin, platelet aggregation and some fibrinolytic parameters in humans." Life Sciences. 55 (21). 1619-1623 (1994)
Malyszko, J. 等人:“人体血清脂质、血清素、血小板聚集和一些纤溶参数之间的关系。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Kotani,I.,et al: "Increased procoagulant and antifibrinolytic activities in the lungs with idiopathic pulmonary fibrosis." Thromb.Res.77(6). 493-504 (1995)
Kotani,I.,et al:“特发性肺纤维化的肺部促凝血和抗纤维蛋白溶解活性增加。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Urano,T.,et al: "Close relationships between serotonergic and fibrinolytic systems revealed by a mono-amine-oxidase inhibitor treatment in rats." Haemostasis. 25(6). 277-282 (1995)
Urano,T.,et al:“通过对大鼠进行单胺氧化酶抑制剂治疗揭示了血清素能系统和纤溶系统之间的密切关系。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
URANO Tetsumei其他文献
URANO Tetsumei的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('URANO Tetsumei', 18)}}的其他基金
Imaging analysis of phosphatidylserine-evoked initiation of coagulation cascade on activated platelets surface.
磷脂酰丝氨酸诱发活化血小板表面凝血级联启动的成像分析。
- 批准号:
21590230 - 财政年份:2009
- 资助金额:
$ 1.28万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Real time imaging analysis of platelets aggregation and thrombus formation under shear stress
剪切应力下血小板聚集和血栓形成的实时成像分析
- 批准号:
18590204 - 财政年份:2006
- 资助金额:
$ 1.28万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Real time imaging analysis of molecular interactions of factors involved in fibrinolysis on cell surface to modify cell migration
实时成像分析细胞表面纤维蛋白溶解相关因子的分子相互作用,以改变细胞迁移
- 批准号:
13670040 - 财政年份:2001
- 资助金额:
$ 1.28万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Analysis of the mechanism to enhance fibrinolysis by a neutralization of the activity of plasminogen activator inhibitor type 1.
通过中和纤溶酶原激活剂抑制剂 1 型的活性来增强纤维蛋白溶解的机制分析。
- 批准号:
10670040 - 财政年份:1998
- 资助金额:
$ 1.28万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似海外基金
Soluble urokinase receptor; a new diagnostic and therapeutic biomarker for nephrotic syndrome
可溶性尿激酶受体;
- 批准号:
18K15988 - 财政年份:2018
- 资助金额:
$ 1.28万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Molecular and cellular biology of the urokinase/urokinase receptor -related vascular remodeling: role in vascular inflammation
尿激酶/尿激酶受体相关血管重塑的分子和细胞生物学:在血管炎症中的作用
- 批准号:
257233201 - 财政年份:2014
- 资助金额:
$ 1.28万 - 项目类别:
Research Grants
Targeting the Urokinase Receptor in Glioblastoma Multiforme
靶向多形性胶质母细胞瘤中的尿激酶受体
- 批准号:
8613477 - 财政年份:2013
- 资助金额:
$ 1.28万 - 项目类别:
Targeting the Urokinase Receptor in Glioblastoma Multiforme
靶向多形性胶质母细胞瘤中的尿激酶受体
- 批准号:
8501950 - 财政年份:2013
- 资助金额:
$ 1.28万 - 项目类别:
Targeting the Urokinase Receptor in Glioblastoma Multiforme
靶向多形性胶质母细胞瘤中的尿激酶受体
- 批准号:
9023503 - 财政年份:2013
- 资助金额:
$ 1.28万 - 项目类别:
Targeting the Urokinase Receptor in Glioblastoma Multiforme
靶向多形性胶质母细胞瘤中的尿激酶受体
- 批准号:
9215655 - 财政年份:2013
- 资助金额:
$ 1.28万 - 项目类别:
STRUCTURE OF UROKINASE RECEPTOR IN COMPLEX TO ITS INHIBITORS
尿激酶受体与其抑制剂复合物的结构
- 批准号:
8363341 - 财政年份:2011
- 资助金额:
$ 1.28万 - 项目类别:
Small-molecule Inhibition of the Interactions of the Urokinase Receptor: A Targe
尿激酶受体相互作用的小分子抑制:一个目标
- 批准号:
7653278 - 财政年份:2009
- 资助金额:
$ 1.28万 - 项目类别:
Molecular and cellular biology of the urokinase/urokinase receptor -related vascular remodeling
尿激酶/尿激酶受体相关血管重塑的分子和细胞生物学
- 批准号:
144939517 - 财政年份:2009
- 资助金额:
$ 1.28万 - 项目类别:
Research Grants